يعرض 1 - 10 نتائج من 41 نتيجة بحث عن '"Samuel F Hunter"', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis

    المؤلفون: George J Wan, Ishveen Chopra, John Niewoehner, Samuel F Hunter

    المصدر: Drugs in Context, Vol 9, Pp 1-7 (2020)

    مصطلحات موضوعية: cost per response, multiple sclerosis, relapse, repository corticotropin injection, Therapeutics. Pharmacology, RM1-950

    وصف الملف: electronic resource

    Relation: https://www.drugsincontext.com/cost-per-response-analysis-of-repository-corticotropin-injection-versus-other-alternative-treatments-for-acute-exacerbations-of-multiple-sclerosis; https://doaj.org/toc/1740-4398

    URL الوصول: https://doaj.org/article/23e6ed5f05954d1eaef8f376ecc49e2e

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis

    المؤلفون: George J Wan, Ishveen Chopra, John Niewoehner, Samuel F Hunter

    المصدر: Drugs in Context, Vol 10, Pp 1-1 (2021)

    مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950

    وصف الملف: electronic resource

    Relation: https://drugsincontext.com/corrigendum-cost-per-response-analysis-of-repository-corticotropin-injection-versus-other-alternative-treatments-for-acute-exacerbations-of-multiple-sclerosis; https://doaj.org/toc/1740-4398

    URL الوصول: https://doaj.org/article/0cdd4ba9613246008d3db3c671fe65fc

    Full Text Finder
    أضف إلى المفضلة
  3. 3
    Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

    المؤلفون: Sibyl Wray, Florian Then Bergh, Annette Wundes, Douglas L. Arnold, Jelena Drulovic, Elzbieta Jasinska, James D. Bowen, Donald Negroski, Robert T. Naismith, Samuel F. Hunter, Mark Gudesblatt, Hailu Chen, Jennifer Lyons, Sai L. Shankar, Shivani Kapadia, Jason P. Mendoza, Barry A. Singer

    المصدر: Advances in Therapy. 39:1810-1831

    مصطلحات موضوعية: Pharmacology (medical), General Medicine

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::77ad905de880352f36f4e160a876434e
    https://doi.org/10.1007/s12325-022-02068-7

    Find this article in full text from Springer Verlag.
    أضف إلى المفضلة
  4. 4
    Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

    المؤلفون: Sibyl Wray, Francois Jacques, Tamara A Miller, Jacqueline A Nicholas, Rafael Arroyo, Lori Travis, Bhupendra Khatri, Magdalena Chirieac, Roopali Gandhi, Nora Roesch, Amelie Rodrigues, Lydie Melas-Melt, Andreea M Rawlings, Samuel F Hunter

    المصدر: Multiple sclerosis journal - experimental, translational and clinical. 8(4)

    مصطلحات موضوعية: Cellular and Molecular Neuroscience, Neurology (clinical)

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2315d05c618c97f219d77501c190b92c
    https://pubmed.ncbi.nlm.nih.gov/36407472

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  5. 5
    Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies

    المؤلفون: Basil Sharrack, Ho Jin Kim, Rany A Aburashed, Thomas F. Scott, Andrew T. Chan, Carlo Pozzilli, Daniel Kantor, Richard A L Macdonell, Nadia Daizadeh, Dominique Dive, Samuel F. Hunter, Jan Lycke, Raed Alroughani, Darren P Baker, Heinz Wiendl, Sara Eichau, Luke Chung, Patrick Vermersch

    المصدر: Neurology and Therapy
    Hunter, Samuel F; Aburashed, Rany A; Alroughani, Raed; Chan, Andrew; Dive, Dominique; Eichau, Sara; Kantor, Daniel; Kim, Ho Jin; Lycke, Jan; Macdonell, Richard A L; Pozzilli, Carlo; Scott, Thomas; Sharrack, Basil; Wiendl, Heinz; Chung, Luke; Daizadeh, Nadia; Baker, Darren P; Vermersch, Patrick (2021). Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies. Neurology and therapy, 10(2), pp. 803-818. Springer 10.1007/s40120-021-00262-3 <http://dx.doi.org/10.1007/s40120-021-00262-3>

    مصطلحات موضوعية: medicine.medical_specialty, Neurology, 610 Medicine & health, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Confirmed disability worsening, Internal medicine, Post-hoc analysis, medicine, Disease-modifying therapy, In patient, 030212 general & internal medicine, Alemtuzumab, Original Research, Expanded Disability Status Scale, business.industry, Functional systems, Long term disability, medicine.disease, Functional system, Confirmed disability improvement, Neurology (clinical), business, 030217 neurology & neurosurgery, medicine.drug

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d7429be1a1b274c059ed9b671eb848
    https://doi.org/10.1007/s40120-021-00262-3

    Find this article in full text from Springer Verlag.
    أضف إلى المفضلة
  6. 6
    Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

    المؤلفون: Colin M. Dayan, Beatriz Lecumberri, Ilaria Muller, Sashiananthan Ganesananthan, Samuel F. Hunter, Krzysztof W. Selmaj, Hans-Peter Hartung, Eva K. Havrdova, Christopher C. LaGanke, Tjalf Ziemssen, Bart Van Wijmeersch, Sven G. Meuth, David H. Margolin, Elizabeth M. Poole, Darren P. Baker, Peter A. Senior

    المصدر: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9:205521732211427

    مصطلحات موضوعية: Cellular and Molecular Neuroscience, Alemtuzumab, disease-modifying therapy, multiple sclerosis, thyroid, Graves’ disease, Hashimoto’s disease, Neurology (clinical), Settore MED/13 - Endocrinologia

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8f13421e3ddd1a0807f2fb37d03bd0
    https://doi.org/10.1177/20552173221142741

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  7. 7
    Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis

    المؤلفون: Ishveen Chopra, George J. Wan, John Niewoehner, Samuel F Hunter

    المصدر: Drugs in Context
    Drugs in Context, Vol 9, Pp 1-7 (2020)

    مصطلحات موضوعية: Marginal cost, medicine.medical_specialty, medicine.medical_treatment, Relapse treatment, multiple sclerosis, 03 medical and health sciences, cost per response, 0302 clinical medicine, medicine, 030212 general & internal medicine, health care economics and organizations, Original Research, relapse, Pharmacology, Response rate (survey), repository corticotropin injection, business.industry, Multiple sclerosis, lcsh:RM1-950, General Medicine, medicine.disease, Economic benefits, lcsh:Therapeutics. Pharmacology, Economic evaluation, Emergency medicine, Molecular Medicine, Plasmapheresis, Observational study, Corrigendum, business, 030217 neurology & neurosurgery

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::344a7e1db70e30cc9ffe6a2b7b76a482
    https://doi.org/10.7573/dic.2020-9-4

    أضف إلى المفضلة
  8. 8
    Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies

    المؤلفون: Luke Chung, Samuel F. Hunter, Barry A Singer, Antonio Bertolotto, Guillermo Izquierdo, Lobat Hashemi, Tjalf Ziemssen, Nadia Daizadeh, William David Honeycutt, Elisabeth Gulowsen Celius, Dimos-Dimitrios Mitsikostas, Salman Afsar, Barbara Kornek, Tamara Miller, Peter A. Senior, Rafael Arroyo, Giancarlo Comi, Eva Havrdova

    المصدر: Neurology and Therapy, Vol 9, Iss 2, Pp 443-457 (2020)
    Neurology and Therapy

    مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, endocrine system, endocrine system diseases, Visual analogue scale, Health-related quality of life, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Post-hoc analysis, Medicine, 030212 general & internal medicine, Adverse effect, RC346-429, Alemtuzumab, Original Research, business.industry, Multiple sclerosis, Thyroid, Thyroid adverse events, medicine.disease, Clinical trial, medicine.anatomical_structure, Neurology, Relapsing-remitting multiple sclerosis, Neurology (clinical), Neurology. Diseases of the nervous system, business, 030217 neurology & neurosurgery, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cd63ac06d46041c4b97e966e3dc953
    https://doaj.org/article/3bcc37fc46e84de69be4eb2c49df7148

    Find this article in full text from Springer Verlag.
    أضف إلى المفضلة
  9. 9
    Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

    المؤلفون: Sibyl, Wray, Florian, Then Bergh, Annette, Wundes, Douglas L, Arnold, Jelena, Drulovic, Elzbieta, Jasinska, James D, Bowen, Donald, Negroski, Robert T, Naismith, Samuel F, Hunter, Mark, Gudesblatt, Hailu, Chen, Jennifer, Lyons, Sai L, Shankar, Shivani, Kapadia, Jason P, Mendoza, Barry A, Singer

    المصدر: Advances in therapy. 39(4)

    مصطلحات موضوعية: Adult, Multiple Sclerosis, Relapsing-Remitting, Fumarates, Recurrence, Dimethyl Fumarate, Humans, Immunosuppressive Agents

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::bd41959579e39a5ea86823fcb638619b
    https://pubmed.ncbi.nlm.nih.gov/35211872

    Find this article in full text from Springer Verlag.
    أضف إلى المفضلة
  10. 10
    Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis

    المؤلفون: Ishveen Chopra, John Niewoehner, Samuel F Hunter, Mary P Panaccio, Jas Bindra, George J. Wan

    المصدر: ClinicoEconomics and Outcomes Research: CEOR

    مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, medicine.medical_treatment, Economics, Econometrics and Finance (miscellaneous), multiple sclerosis, Internal medicine, medicine, Sensitivity analyses, acute exacerbation, quality-adjusted life-year, health care economics and organizations, Original Research, Acthar® Gel, repository corticotropin injection, business.industry, Health Policy, Multiple sclerosis, cost-effectiveness analysis, Cost-effectiveness analysis, medicine.disease, Alternative treatment, Quality-adjusted life year, ClinicoEconomics and Outcomes Research, Plasmapheresis, business, After treatment

    وصف الملف: text/html

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d3bfc2c0f70df4556e5cfec5040173
    https://www.dovepress.com/cost-effectiveness-of-repository-corticotropin-injection-for-the-treat-peer-reviewed-fulltext-article-CEOR

    PDF full text from Publisher Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء